Heron Therapeutics, Inc. V. Mylan Pharmaceuticals Inc. - 1:24-cv-00043

Heron Therapeutics, Inc. V. Mylan Pharmaceuticals Inc. (Case No. 1:24-cv-00043), filed on Jan 11, 2024 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:24-cv-00043
Filing Date
Jan 11, 2024
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Delaware
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Heron Therapeutics, Inc. -
Mylan Pharmaceuticals Inc. -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jan 18, 2024MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Isaac S. Ashkenazi, Christopher P. Hill, and Mark Russell Sperling - filed by Heron Therapeutics, Inc.. (Tigan, Jeremy) (Entered: 01/18/2024)PACER Document
Jan 18, 2024SO ORDERED, re 8 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Isaac S. Ashkenazi, Christopher P. Hill, and Mark Russell Sperling filed by Heron Therapeutics, Inc. Signed by Judge William C. Bryson on 1/18/2024. (mpb) (Entered: 01/18/2024)PACER Document
Jan 26, 2024Joint Letter to The Honorable William C. Bryson from Jeremy A. Tigan regarding Consolidation - re (12 in 1:24-cv-00043-WCB, 34 in 1:23-cv-01015-WCB) Stipulation. (Tigan, Jeremy) (Entered: 01/26/2024)PACER Document
Jan 26, 2024STIPULATION and [Proposed] Order to Consolidate and Extend Time by Heron Therapeutics, Inc.. (Tigan, Jeremy) (Entered: 01/26/2024)PACER Document
Jan 26, 2024STIPULATION AND ORDER consolidating cases. Signed by Judge William C. Bryson on 1/26/2024. Associated Cases: 1:23-cv-01015-WCB, 1:24-cv-00043-WCB(gva) (Entered: 01/26/2024)PACER Document
Feb 2, 2024Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc., Corporate Parent Viatris Inc. for Mylan Pharmaceuticals Inc. filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 02/02/2024)PACER Document
Feb 2, 2024ANSWER to 1 Complaint,Separate Defenses, and, COUNTERCLAIM against Heron Therapeutics, Inc. by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 02/02/2024)PACER Document
Jan 18, 2024Pro Hac Vice Fee - Credit Card Payment received for Bruce M. Wexler, Isaac S. Ashkenazi, Christopher P. Hill, and Mark Russell Sperling. ( re 8 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Isaac S. Ashkenazi, Christopher P. Hill, and Mark Russell Sperling )( Payment of $ 200, receipt number ADEDC-4317723).(Tigan, Jeremy) (Entered: 01/18/2024)PACER Document
Jan 20, 2024ORAL ORDER: The parties are directed to advise the court by letter whether this case is suitable for consolidation with Heron Therapeutics, Inc. v. Mylan Pharmaceuticals Inc., No. 23-1015. The parties letters will be due for filing by January 26, 2024. Signed by Judge William C. Bryson on 1/20/2024. (gva) (Entered: 01/20/2024)PACER Document
Jan 17, 2024Case Assigned to Judge William C. Bryson of the United States Court of Appeals for the Federal Circuit, due to related cases. Please include the initials of the Judge (WCB) after the case number on all documents filed. (rjb)PACER Document
Jan 22, 2024Pro Hac Vice Attorney Christopher P. Hill,Mark Russell Sperling,Isaac S. Ashkenazi,Bruce M. Wexler for Heron Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk)PACER Document
Jan 26, 2024Case associated with lead case: Create association to 1:23-cv-01015-WCB. ALL FILINGS SHALL BE MADE IN THE LEADE CASE 1:23-cv-01015-WCB ONLY. (smg)PACER Document